Cargando…

Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics

The recognition of invading pathogens and endogenous molecules from damaged tissues by toll-like receptors (TLRs) triggers protective self-defense mechanisms. However, excessive TLR activation disrupts the immune homeostasis by sustained pro-inflammatory cytokines and chemokines production and conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Wei, Xiong, Ye, Li, Qiang, Yang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516312/ https://www.ncbi.nlm.nih.gov/pubmed/28769820 http://dx.doi.org/10.3389/fphys.2017.00508

Ejemplares similares

Molecular Regulation of Toll-like Receptors in Asthma and COPD
por: Zuo, Li, et al.
Publicado: (2015)

Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity
por: Raby, Anne-Catherine, et al.
Publicado: (2018)

Toll-Like Receptors in Liver Fibrosis: Cellular Crosstalk and Mechanisms
por: Yang, Ling, et al.
Publicado: (2012)

Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function
por: Alonso-Pérez, Ana, et al.
Publicado: (2018)

Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
por: García-Rodríguez, Carmen, et al.
Publicado: (2018)

Toll-Like Receptor 4 and Blood Pressure: Lessons From Animal Studies
por: Nunes, Kenia Pedrosa, et al.
Publicado: (2019)

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease
por: Wu, Linyu, et al.
Publicado: (2022)

Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients
por: Aly, Rofyda H., et al.
Publicado: (2020)

Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies
por: Yedavilli, Sneha, et al.
Publicado: (2022)

Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
por: Vilahur, Gemma, et al.
Publicado: (2014)

Molecular Characterization of Two Toll Receptors in Hyriopsis cumingii and Their Potential Roles in Antibacterial Response
por: Huang, Ying, et al.
Publicado: (2019)

Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4
por: Húngaro, Talita Guerreiro Rodrigues, et al.
Publicado: (2020)

Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma
por: Guan, Hewen, et al.
Publicado: (2023)

Bacterial Signal Peptides- Navigating the Journey of Proteins
por: Kaushik, Sharbani, et al.
Publicado: (2022)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

Cloning and Characterization of Two Toll Receptors (PcToll5 and PcToll6) in Response to White Spot Syndrome Virus in the Red Swamp Crayfish Procambarus clarkii
por: Huang, Ying, et al.
Publicado: (2018)

Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
por: Savva, Athina, et al.
Publicado: (2013)

Toll‐like receptor 4: A promising therapeutic target for pneumonia caused by Gram‐negative bacteria
por: Ding, Junying, et al.
Publicado: (2019)

Therapeutic Use of Exercising in Hypoxia: Promises and Limitations
por: Millet, Gregoire P., et al.
Publicado: (2016)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Exercise Alleviates the Apolipoprotein A5-Toll-Like Receptor 4 Axis Impairment in Mice With High-Fat Diet-Induced Non-alcoholic Steatohepatitis
por: Yu, Yang, et al.
Publicado: (2021)

Multipotent stem cells of the heart—do they have therapeutic promise?
por: Leite, Camila F., et al.
Publicado: (2015)

Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
por: Lepper, Philipp M., et al.
Publicado: (2010)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

The journey of preproteins across the chloroplast membrane systems
por: Ballabani, Gent, et al.
Publicado: (2023)

Toll-like receptors in cerebral ischemic inflammatory injury
por: Wang, Yan-Chun, et al.
Publicado: (2011)

Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
por: Mukherjee, Suprabhat, et al.
Publicado: (2023)

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
por: Linden, Fabian, et al.
Publicado: (2014)

Physical Exercise Repairs Obstructive Jaundice-Induced Damage to Intestinal Mucosal Barrier Function via H(2)S-Mediated Regulation of the HMGB1/Toll Like Receptors 4/Nuclear Factor Kappa B Pathway
por: Shao, Changfeng, et al.
Publicado: (2022)

Cloning and Analysis of Gene Expression of Two Toll Receptors in Freshwater Pearl Mussel Hyriopsis cumingii
por: Huang, Ying, et al.
Publicado: (2018)

mTOR Inhibition: A Promise for a Young Heart
por: Cau, Stefany B. A., et al.
Publicado: (2012)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection
por: Mukherjee, Rukmini, et al.
Publicado: (2021)

Toll-Like Receptors: General Molecular and Structural Biology
por: Behzadi, Payam, et al.
Publicado: (2021)

Role of self-organising myddosome oligomers in inflammatory signalling by Toll-like receptors
por: Gay, Nicholas J.
Publicado: (2019)

Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies
por: Caplan, Ian F., et al.
Publicado: (2018)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

Activation of the Toll-like receptor 2 signaling pathway inhibits the proliferation of HCC cells in vitro
por: Chen, Yi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1eh6r6km44c4keuuftaio8sbor